MedPath

湖北睿泽药业有限公司

Ownership
-
Established
2021-11-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

养血安神糖浆

Approval Number
国药准字Z42022064
Approval Date
Sep 28, 2021
NMPA

妇科白带膏

Approval Number
国药准字Z42022059
Approval Date
Sep 28, 2021
NMPA

肥儿糖浆

Approval Number
国药准字Z42022058
Approval Date
Sep 28, 2021
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H42022827
Approval Date
Sep 28, 2021
NMPA

益母草膏

Approval Number
国药准字Z42022065
Approval Date
Sep 28, 2021
NMPA

川贝清肺糖浆

Approval Number
国药准字Z42022057
Approval Date
Sep 28, 2021
NMPA

小儿止咳糖浆

Approval Number
国药准字Z42022063
Approval Date
Sep 28, 2021
NMPA

健脾糖浆

Approval Number
国药准字Z42022060
Approval Date
Sep 28, 2021
NMPA

脑乐静

Approval Number
国药准字Z42022062
Approval Date
Sep 28, 2021
NMPA

金银花露

Approval Number
国药准字Z42022061
Approval Date
Sep 28, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.